Annual SGA
$5.29 M
-$867.30 K-14.09%
March 31, 2023
Summary
- As of March 2, 2025, MDNA annual SGA is $5.29 million, with the most recent change of -$867.30 thousand (-14.09%) on March 31, 2023.
- During the last 3 years, MDNA annual SGA has risen by +$3.42 million (+182.29%).
Performance
MDNA SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly SGA
$1.22 M
+$200.70 K+19.62%
June 30, 2023
Summary
- As of March 2, 2025, MDNA quarterly SGA is $1.22 million, with the most recent change of +$200.70 thousand (+19.62%) on June 30, 2023.
- Over the past year, MDNA quarterly SGA has dropped by -$278.10 thousand (-18.52%).
Performance
MDNA Quarterly SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM SGA
-$235.53 M
-$4.99 M-2.17%
June 30, 2023
Summary
- As of March 2, 2025, MDNA TTM SGA is -$235.53 million, with the most recent change of -$4.99 million (-2.17%) on June 30, 2023.
- Over the past year, MDNA TTM SGA has dropped by -$241.67 million (-3932.12%).
Performance
MDNA TTM SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Selling, General & Administrative Expenses Formula
SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development
MDNA Selling, General & Administrative Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -14.1% | -18.5% | -3932.1% |
| 3 y3 years | +182.3% | +134.9% | -10000.0% |
| 5 y5 years | +126.0% | +160.8% | -10000.0% |
MDNA Selling, General & Administrative Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -14.1% | -7.2% | -22.1% | -16.4% | +27.4% | at low |
| 5 y | 5-year | -14.1% | -68.2% | -23.4% | -60.6% | +206.8% | at low |
| alltime | all time | -14.1% | -93.2% | -34.6% | -99.6% | >+9999.0% | at low |
Medicenna Therapeutics Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2023 | - | $1.22 M(+19.6%) | $5.01 M(-5.3%) |
| Mar 2023 | $5.29 M(-14.1%) | $1.02 M(-29.6%) | $5.29 M(-8.6%) |
| Dec 2022 | - | $1.45 M(+10.5%) | $5.79 M(-2.0%) |
| Sep 2022 | - | $1.31 M(-12.4%) | $5.91 M(-3.8%) |
| Jun 2022 | - | $1.50 M(-1.3%) | $6.15 M(-0.2%) |
| Mar 2022 | $6.16 M(+25.4%) | $1.52 M(-3.1%) | $6.16 M(-0.9%) |
| Dec 2021 | - | $1.57 M(+1.3%) | $6.21 M(-0.4%) |
| Sep 2021 | - | $1.55 M(+2.6%) | $6.24 M(+4.9%) |
| Jun 2021 | - | $1.51 M(-4.1%) | $5.95 M(+20.0%) |
| Mar 2021 | $4.91 M(+162.0%) | $1.58 M(-1.3%) | $4.96 M(+28.4%) |
| Dec 2020 | - | $1.60 M(+26.7%) | $3.86 M(+36.7%) |
| Sep 2020 | - | $1.26 M(+142.2%) | $2.83 M(+37.8%) |
| Jun 2020 | - | $520.80 K(+8.1%) | $2.05 M(+4.2%) |
| Mar 2020 | $1.87 M | $481.80 K(-14.3%) | $1.97 M(+4.4%) |
| Dec 2019 | - | $562.10 K(+15.5%) | $1.88 M(+7.8%) |
| Sep 2019 | - | $486.70 K(+11.2%) | $1.75 M(+5.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2019 | - | $437.60 K(+9.9%) | $1.65 M(-1.9%) |
| Mar 2019 | $1.68 M(-28.1%) | $398.00 K(-6.5%) | $1.68 M(-3.7%) |
| Dec 2018 | - | $425.80 K(+9.0%) | $1.75 M(-17.1%) |
| Sep 2018 | - | $390.80 K(-16.7%) | $2.11 M(-10.4%) |
| Jun 2018 | - | $469.10 K(+1.2%) | $2.36 M(+1.9%) |
| Mar 2018 | $2.34 M(-23.5%) | $463.40 K(-41.2%) | $2.31 M(-37.8%) |
| Dec 2017 | - | $787.80 K(+23.9%) | $3.72 M(+9.5%) |
| Sep 2017 | - | $635.80 K(+49.4%) | $3.40 M(+22.8%) |
| Jun 2017 | - | $425.50 K(-77.2%) | $2.76 M(+17.8%) |
| Mar 2017 | $3.06 M(+753.1%) | $1.87 M(+302.5%) | $2.35 M(+385.0%) |
| Dec 2016 | - | $464.50 K(+9783.0%) | $483.90 K(+2394.3%) |
| Sep 2016 | - | $4700.00(-43.4%) | $19.40 K(-85.2%) |
| Jun 2016 | - | $8300.00(+29.7%) | $131.40 K(-2.7%) |
| Mar 2016 | $358.60 K | $6400.00(-94.5%) | $135.10 K(+5.0%) |
| Sep 2015 | - | $116.70 K(+872.5%) | $128.70 K(+972.5%) |
| Jun 2015 | - | $12.00 K | $12.00 K |
FAQ
- What is Medicenna Therapeutics annual SGA?
- What is the all time high annual SGA for Medicenna Therapeutics?
- What is Medicenna Therapeutics annual SGA year-on-year change?
- What is Medicenna Therapeutics quarterly SGA?
- What is the all time high quarterly SGA for Medicenna Therapeutics?
- What is Medicenna Therapeutics quarterly SGA year-on-year change?
- What is Medicenna Therapeutics TTM SGA?
- What is the all time high TTM SGA for Medicenna Therapeutics?
- What is Medicenna Therapeutics TTM SGA year-on-year change?
What is Medicenna Therapeutics annual SGA?
The current annual SGA of MDNA is $5.29 M
What is the all time high annual SGA for Medicenna Therapeutics?
Medicenna Therapeutics all-time high annual SGA is $6.16 M
What is Medicenna Therapeutics annual SGA year-on-year change?
Over the past year, MDNA annual SGA has changed by -$867.30 K (-14.09%)
What is Medicenna Therapeutics quarterly SGA?
The current quarterly SGA of MDNA is $1.22 M
What is the all time high quarterly SGA for Medicenna Therapeutics?
Medicenna Therapeutics all-time high quarterly SGA is $1.87 M
What is Medicenna Therapeutics quarterly SGA year-on-year change?
Over the past year, MDNA quarterly SGA has changed by -$278.10 K (-18.52%)
What is Medicenna Therapeutics TTM SGA?
The current TTM SGA of MDNA is -$235.53 M
What is the all time high TTM SGA for Medicenna Therapeutics?
Medicenna Therapeutics all-time high TTM SGA is -$11.90 K
What is Medicenna Therapeutics TTM SGA year-on-year change?
Over the past year, MDNA TTM SGA has changed by -$241.67 M (-3932.12%)